Clinical Trial: Trial of Curcumin in Cutaneous T-cell Lymphoma Patients

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional




Official Title: Phase II Trial of Curcumin in Cutaneous T-cell Lymphoma Patients

Brief Summary: The goal of this clinical research study is to learn if treatment with curcumin can help to decrease the size of lesions and/or decrease itching in patients with MF or SS. The safety of curcumin will also be studied.